Grifols GRFS
NASDAQ GRFS
$7.50 -0.04 (-0.53%)
At close: Oct 21, 2026 · 4:00 PM EDT

Grifols (GRFS) Current Leases (2015 - 2016)

Updated

Grifols (GRFS) recorded Current Leases of $6.9 million in the quarter ended Mar 31, 2016, up 7.6% from the prior quarter.

Analysis

Grifols (GRFS) Current Leases (2015 - 2016) Analysis & Trends

As of Dec 31, 2015, Grifols reported Current Leases of $6.5 million.

  • Across earlier years, Current Leases came in at -$21.88 million in the year ended Dec 31, 2014 and -$26.11 million in the year ended Dec 31, 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Grifols 5.11 Bn 1.45 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2016 103.37 Mn
Dec 31, 2015 86.96 Mn
API Access

Grifols Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=GRFS&period=max&api_key=YOUR_API_KEY